74 filings
Page 3 of 4
10-K
oxsnk5ksigbspccl t3m
24 Mar 22
Annual report
4:40pm
8-K
0wfugxa
24 Mar 22
Imago BioSciences Reports Fourth Quarter and Full Year 2021 Financial Results
4:34pm
8-K
lc4552sj 12toi
23 Mar 22
Imago BioSciences Appoints Michael Arenberg to Chief Operating and Business Officer
4:21pm
8-K
7wylt c91y
12 Jan 22
Other Events
4:16pm
8-K
qmrj dn1j
13 Dec 21
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2021
8:32am
8-K
sr3wim2
19 Nov 21
Imago BioSciences Appoints Laurie Keating to Board of Directors
4:15pm
8-K
arih ql976obe06u
10 Nov 21
Imago BioSciences Reports Third Quarter 2021 Financial Results and Provides Recent Business Updates
4:17pm
8-K
42i5 pej71rni5
30 Sep 21
Departure of Directors or Certain Officers
4:54pm
10-Q
tfoez
19 Aug 21
Quarterly report
4:19pm
8-K
pkl21
19 Aug 21
Imago BioSciences Reports Second Quarter 2021 Financial Results and Provides Recent Business Updates
4:08pm
8-K
5i1d5deqai2lcxitkh
26 Jul 21
Imago BioSciences, Inc. Announces Exercise of Underwriters’ Option to Purchase Additional Shares
5:00pm
S-8
wbavrlxt3ynlqso
21 Jul 21
Registration of securities for employees
12:00am
8-K
8s03as
20 Jul 21
Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering
5:30pm
424B4
prtzj55jekc laxn2gbx
16 Jul 21
Prospectus supplement with pricing info
4:43pm
EFFECT
fkda2pds5c3
16 Jul 21
Notice of effectiveness
12:15am
S-1MEF
et7fjv5 obvd6
15 Jul 21
Registration of additional securities for an S-1
6:33pm
CERT
olokwt47z xbhru9ult
15 Jul 21
Certification of approval for exchange listing
10:53am
8-A12B
fbnie
13 Jul 21
Registration of securities on exchange
4:07pm